| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 284 / 428 | 33rd | Q3 |
| Cancer Research | 189 / 233 | 19th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Treatment and Research
Cancer Treatment and Research is Scopus-indexed (Q3, CiteScore 2.3). Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 0927-3042Verify ISSN ↗2509-8497Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Cancer Treatment and Research indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2013–present (also 1988–2011), best quartile Q3, CiteScore 2.3.
What quartile is Cancer Treatment and Research in Scopus?
Cancer Treatment and Research is Q3 in Oncology (rank 284 of 428) and Q4 in Cancer Research (rank 189 of 233), by CiteScore 2025.
What is the impact factor of Cancer Treatment and Research?
Cancer Treatment and Research is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.3, quartile Q3, 33rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Who publishes Cancer Treatment and Research and what is its ISSN?
Cancer Treatment and Research is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 0927-3042 and its online ISSN is 2509-8497.
Is Cancer Treatment and Research in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Cancer Treatment and Research open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Cancer Treatment and Research? — open metrics via OpenAlex
Cancer Treatment and Research has an h-index of 82 and a 2-year mean of 2.11 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q3. On 2-year citations it ranks #188 of 424 Scopus journals in Oncology.
Cancer Treatment and Research published 15 papers in 2025; its busiest recent year was 2023 with 98. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Cancer Treatment and Research? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.